Navigation Links
New drug helps boost cancer treatment

Researchers at the Sloane Kettering Cancer Center, New York have achieved a breakthrough of sorts in cancer treatment, by designing a new drug, which attaches itself to a key position on cancer cells and gives new potency to failing chemotherapy drugs thereby extending survival of advanced colorectal cancer patients.

IMC-C225, the new drug which is actually a monoclonal antibody, is designed to interfere with the epidermal growth factor receptor, a molecular structure that, when blocked, makes it more difficult for tumor cells to reproduce.

To test the efficacy of the drug, the oncologists prescribed the new drug to a group of patients with cancer. All of the 120 patients given IMC-C225 were diagnosed with cancer that was progressing. When given the drug 22.5 percent of the patients achieved a partial response to therapy -- that is, their tumors were reduced by more than 50 percent. Another 7 percent of patients were able to have their disease stabilized.

Further studies of the drug are continuing in colorectal, head, neck, pancreatic and lung cancer. The monoclonal antibody was well tolerated by the patients. The most common side effect attributed to the drug was an acne-like skin rash that occurs because skin cells also contain large amounts of epidermal growth factor receptors.
'"/>




Page: 1

Related medicine news :

1. Sperm washing helps couples – Breakthrough in focu
2. Patient’s perception of health status helps in better recover
3. New vaccine helps allergy and asthma patients
4. New vaccine helps allergy and asthma patients
5. Now umbilical cord helps in stroke treatment.
6. Spirituality helps lessen arthritic pain
7. Supplement helps cardiac surgery
8. Antidepressant helps obesity
9. Dopamine helps stroke survivors
10. Radiotherapy helps in colon cancer
11. Genetics helps in attacking cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... Texas (PRWEB) , ... May 04, 2016 , ... May ... awareness in people across the United States. Dermatologist Dr. Ellen Turner is encouraging her ... dermatology experts’ advice and focus on skin safety and health now and in the ...
(Date:5/4/2016)... ... May 04, 2016 , ... Dr. Elyson and Dr. Assili, ... surgery at their office. Wisdom tooth removal, a common dental procedure, is performed for ... often are improperly erupted, resulting in risks of complications. By providing wisdom tooth removal ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nordic Naturals announces another ... metabolic health. This synergistic combination of omega-3 fatty acids and potent antioxidants contains ... of reduced glutathione and 200 mg of N-Acetylcysteine (NAC). , Each nutrient ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of Queen ... forever with a same-day LASIK procedure at Christenbury Eye Center. The entrepreneur ... Christenbury performed her surgery the same day as her in-office consultation and eye exam. ...
(Date:5/4/2016)... ... May 04, 2016 , ... Pharmacy ... announced that it was chosen as the Pharmaceutical News Provider of the Year ... awards acknowledge the hard work and dedication of community members who strive to ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... completion of an alternative public offering (APO). This was ... operating company, Valeritas, Inc. and a private placement of ... at $5.00 per share. Under the terms ... 3, 2016, Valeritas Holdings, Inc. will trade on the ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute lymphocytic Leukemia Market and ... their offering.       (Logo: ... Lymphocytic Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Lymphocytic Leukemia epidemiology, ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, ... contracted rheumatic fever, which damaged his heart. He continued ... But by June 2013, Shepherd,s heart was giving out ... death. On June 20, 2013, the Mesa, ... Artificial Heart (TAH-t). Like a heart transplant, the SynCardia ...
Breaking Medicine Technology: